高氯酸镱对大鼠背根神经元细胞毒性及膜上钾通道的影响

研究了高氯酸镱(Yb(ClO4)3)诱导大鼠背根神经(DRG)元凋亡、引起胞内钙离子浓度变化以及对膜上钾离子通道的影响.急性分离大鼠DRG细胞,用不同浓度的Yb(ClO4)3处理DRG细胞24和96h,采用流式细胞仪和激光共聚焦法,检测细胞的凋亡和细胞内钙离子荧光强度的变化.利用全细胞膜片钳法,记录Yb(ClO4)3对细胞膜上不同钾通道电流的影响.结果表明,10,100,1000μmol/L Yb(ClO4)3处理DRG神经元24h,细胞基本不表现凋亡;处理96h,细胞出现明显的凋亡(P0.05～0.01),尤其是1000μmol/L Yb(ClO4)3,凋亡率达到了(55.23±3.76)%(P0.01).经Yb(ClO4)3孵育的DRG神经元胞内的Ca2+的荧光强度显著增大;Yb(ClO4)3抑制背根神经节纤维和神经元突起的生长.Yb(ClO4)3抑制DRG神经元膜上的钾电流,胞内和胞外的Yb(ClO4)3作用钾通道的部位不同.细胞外液中的Yb(ClO4)3不同程度地阻断了瞬间外向钾电流IA,对延迟整流钾电流几乎没影响;往电极内液中加入同样浓度的Yb(ClO4)3对IA影响很小,却特异性地阻断了延迟整流钾电流IK.10μmol/L Yb(ClO4)3使IA的激活和失活过程都显著右移,延长了瞬间外向钾电流达到峰值的时间和快速失活时间常数,增加神经元的兴奋性.     

水稻耐铁毒基因型筛选及边缘细胞对铁毒的反应特性

以相对耐铁的水稻品种"中优9288"和敏感品种"汕优10号"作为实验材料,研究了铁毒对水稻离体边缘细胞的影响。结果表明,随铁浓度的升高(除400μmol/LFe2 外),处理时间的延长,边缘细胞存活率下降:400μmol/L浓度铁处理时,边缘细胞存活率增加;低浓度铁能促进PME活性增长,高浓度铁则抑制PME活性。     

反义c-Ha-ras寡聚核苷酸对转化细胞的生长抑制及其p21蛋白合成的抑制

本文合成了两个15聚核苷酸AS-1和AS-2,前者与c-Ha-ras mRNA的前三个密码子及其上游的核蛋白体结合点附近的单链区互补,后者与细胞核内未成熟c-Ha-rag RNA第一内含子3′端及第二外显子5′端区域互补,它们可分别阻断c-Ha-ras mRNA的翻译和拼接过程,从而降低c-Ha-ras癌基因的表达水平,抑制了转化细胞的增殖。这种抑制作用随浓度的增加(从4μmol/L至10μmol/L)而增加,加入AS-1或AS-2 12h后抑制作用达到高峰,以后逐渐下降。用ELISA方法测定转化细胞中c-Ha-ras产物p21蛋白水平,结果显示增殖受抑制细胞p21水平较对照细胞降低30％左右。     

海洋珍珠生物提取液对人宫颈癌Siha细胞增殖与凋亡作用的影响

为探讨海洋珍珠生物提取液对宫颈癌Siha细胞株增殖和凋亡的影响,采用MTT法检测了细胞增殖情况,在流式细胞仪用Annexin V和PI双染检测了细胞的凋亡率,PI单染法测定了细胞周期,Hoechst 33258/PI荧光染色法观测了Siha细胞的形态学改变,RT-PCR法测定了宫颈癌Siha细胞株内Bcl-2,Bax基因表达。结果表明,海洋珍珠生物提取液在一定质量浓度范围内,以浓度依赖性的方式抑制宫颈癌Siha细胞的生长(P0.05);以0,6,30和60μg/mL海洋珍珠生物提取液处理细胞24 h,Siha细胞早期凋亡率分别为5%,7.1%,32.25%和31.95%,晚期凋亡比例为0.45%,2.85%,8.55%和23.2%;荧光显微镜下细胞呈现典型的凋亡性改变;RT-PCR显示海洋珍珠生物提取液处理后宫颈癌Siha细胞内的Bcl-2 mRNA表达降低,Bax mRNA表达升高。提示海洋珍珠生物提取液以浓度依赖性的方式抑制宫颈癌Siha细胞增殖,并通过降低Bcl-2 mRNA,升高Bax mRNA来诱导细胞凋亡。     

白藜芦醇衍生物的合成及抑制宫颈癌HeLa细胞肿瘤活性

以白藜芦醇、氯乙酰氯、对甲苯磺酰氯、对甲苯甲酰氯为原料,合成9种新的白藜芦醇衍生物,其结构经IR,1HNMR,13C NMR和HRMS所表征.用3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐(MTT)法测试了目标化合物抑制宫颈癌HeLa细胞的肿瘤活性,结果表明:化合物4a,6a,7b,8b和11c对HeLa细胞的抑制活性比白藜芦醇高,其中化合物6a和8b的抑制效果最明显,其IC50值分别为22.7和18.0μmol/L,活性高于白藜芦醇(IC50=114μmol/L),且在150μmol/L浓度下对HeLa细胞的抑制率达95.5%和87.7%.     

含哌嗪酰胺类杨梅素衍生物的合成及生物活性

以杨梅苷、哌嗪和各种芳香酸为原料,通过甲基化保护羟基和脱苷形成选择性单一的杨梅素中间体,然后以三步取代反应连接哌嗪和芳香酸,合成了13个新型含哌嗪酰胺类杨梅素衍生物.采用四甲基偶氮唑盐(MTT)比色法测试了化合物对人类乳腺癌细胞(MDA-MB-231)体外增殖的抑制活性.结果表明,大多数含哌嗪酰胺的杨梅素衍生物对MDA-MB-231细胞表现出较好的抑制活性.当浓度为1μmol/L时,化合物4a和4i的抑制活性均高于阳性对照药盐酸表阿霉素;当浓度为10μmol/L时,化合物4h和4i的抑制活性高达86.7%和83.6%.     

基于阵列微流控细胞芯片的植物组分抗氧化活性分析

设计并制作了一种集成有8个重复6×6细胞培养单元的阵列微流控细胞芯片,以实现细胞培养和系列植物组分的细胞抗氧化活性(Cellular antioxidant activity,CAA)分析.芯片主要包含聚二甲基硅烷盖片、288个圆形培养腔体,48个独立平行通道的玻璃基底层,一次可完成8个样本的6个浓度筛选,并可在酶标仪上实现测试.槲皮素、芦丁和山奈酚等植物组分与芯片上培养的细胞作用24 h,细胞存活率大于90％.以芯片上培养的人肝癌细胞HepG2为细胞载体,以2',7'-二氯荧光素-乙酰乙酸酯(2',7'-Dichlorofluorescin diace-tate,DCFH-DA)为荧光探针,采用2,2'-偶氮二异丁基脒二盐酸盐(2,2'-azobis(2-amidinopropane)dihydrochlo-ride,ABAP)为细胞内活性氧(Reactive oxygen species,ROS)引发剂,测得槲皮素、芦丁、山奈酚等植物组分的CAA unit分别为71.42±0.19、74.31 ±0.36和69.92±0.09((x)±s,n=3),IC50分别为(7.20±0.06) μmol/L,(52.06±0.14) μmol/L,(32.55±0.03) μmol/L((x)±s,n=3).     

含香豆素结构的1,4-戊二烯-3-酮类衍生物的合成及生物活性

为了开发新型抗肿瘤药物候选分子,将香豆素单元有机融入1,4-戊二烯-3-酮分子骨架中,设计合成了16个结构新颖的单羰基姜黄素衍生物.在确证目标分子结构后,采用甲基四氮唑盐(MTT)比色法测试了其对胃癌SGC7901细胞和肝癌HepG2细胞体外增殖的抑制活性.生物活性测试结果表明,绝大多数目标分子均能显著抑制SGC7901和HepG2细胞的体外增殖.其中,化合物4c和4j对SGC7901细胞的半数抑制浓度(IC50)为0.22和0.27μmol/L,其活性显著优于对照药剂表柔比星(1.23μmol/L).同时,化合物4l对HepG2细胞的IC50值(0.47μmol/L)也显著优于表柔比星(2.30μmol/L).细胞形态学研究结果进一步证实,含香豆素结构1,4-戊二烯-3-酮衍生物能显著抑制多种肿瘤细胞的体外增殖,可作为高效抗肿瘤药物候选分子进行深度开发.     

重组质粒pIRES-EGFP-BCL 11B电转染幼稚T细胞的可视化研究

将BCL 11B基因插入pIRES-EGFP构建重组质粒真核表达载体pIRES-EGFP-BCL 11B,采用电转染法将重组质粒转入人幼稚T细胞,转染24 h后,用原子力显微镜(AFM)观察转染前后细胞的表面形态以及生物物理性质的变化.转染72 h后,用CCK-8试剂检测幼稚T细胞的增殖情况.分别对空转的幼稚T细胞组、空载体转染组(pIRES-EGFP naked plasmid)、重组载体转染组(pIRES-EGFP-BCL 11B recombinant vector)、无电转无质粒的幼稚T细胞组进行实验.结果表明,4组幼稚T细胞的体积、高度、半宽度、粗糙度、表面颗粒大小等参数发生了变化,细胞杨氏模量以及细胞硬度也呈现很大变化,CCK-8结果显示,重组质粒pIRES-EGFP-BCL 11B电转染人幼稚T细胞后影响细胞的增殖.     

壳交联pH响应型PLGA载药微球的制备与研究

首先采用一次乳化法制备出PLGA[聚(乳酸-羟基乙酸)]纳米微球,并通过静电吸附将阳离子聚合物壳聚糖修饰到PLGA微球表面,然后以香草醛为交联剂对壳聚糖进行化学交联,得到一种壳交联的p H响应型纳米微球(PCV),微球粒径为(277.60±38.01)nm,表面电位为(21.60±4.51)m V.微球稳定性评价结果显示微球在24 h内粒径变化较小;流式细胞仪检测显示细胞对PCV微球的摄取量比未经修饰的PLGA微球的摄取量高;空白微球细胞毒性实验表明在空白微球浓度小于80μg/m L时细胞的存活率达93.24%.以多西他赛(DTX)为模型药物进行包载,该纳米微球DTX的载药率为7.48%,包封率为34.98%;体外药物释放实验显示,该微球在p H=5.0环境下孵育90 h的药物积累释放率达58.66%,而在p H=7.4的环境下的药物积累释放率为50.63%;此外,载DTX微球毒性试验结果表明该载药微球对A549肺癌细胞有较强的杀伤作用,其IC50值可达0.0009μg/m L.     

Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells

Liver cancer has become one of the major types of cancer with high mortality and liver cancer is not responsive to the current cytotoxic agents used in chemotherapy. The purpose of this study was to examine the in vitro cytotoxicity of goniothalamin on human hepatoblastoma HepG2 cells and normal liver Chang cells. The cytotoxicity of goniothalamin against HepG2 and liver Chang cell was tested using MTT cell viability assay, LDH leakage assay, cell cycle flow cytometry PI analysis, BrdU proliferation ELISA assay and trypan blue dye exclusion assay. Goniothalamin selectively inhibited HepG2 cells [IC?? = 4.6 (±0.23) μM in the MTT assay; IC?? = 5.20 (±0.01) μM for LDH assay at 72 hours], with less sensitivity in Chang cells [IC?? = 35.0 (±0.09) μM for MTT assay; IC?? = 32.5 (±0.04) μM for LDH assay at 72 hours]. In the trypan blue dye exclusion assay, the Viability Indexes were 52 ± 1.73% for HepG2 cells and 62 ± 4.36% for Chang cells at IC?? after 72 hours. Cytotoxicity of goniothalamin was related to inhibition of DNA synthesis, as revealed by the reduction of BrdU incorporation. At 72 hours, the lowest concentration of goniothalamin (2.3 μL) retained 97.6% of normal liver Chang cells proliferation while it reduced HepG2 cell proliferation to 19.8% as compared to control. Besides, goniothalamin caused accumulation of hypodiploid apoptosis and different degree of G2/M arrested as shown in cell cycle analysis by flow cytometry. Goniothalamin selectively killed liver cancer cell through suppression of proliferation and induction of apoptosis. These results suggest that goniothalamin shows potential cytotoxicity against hepatoblastoma HepG2 cells.     

Apoptosis and membrane permeabilisation induced by macranthoside B on HL-60 cells

Triterpene saponins are throught to be potential anti-tumour agents in many cell types. This study aims to evaluate the cytotoxic activity and mechanism of a triterpene saponin, macranthoside B (MB), isolated from Lonicera macranthoides Hand.-Mazz. (Caprifoliaceae). A cell viability assay showed that MB inhibited cell growth of a panel of six cancer cell lines, especially in human acute promyelocytic leukaemia HL-60 cells, with an IC50 value of 3.8 μmol. A hypodiploid cells assay and an annexin-V-FITC/PI double staining assay showed a significant increase of apoptosis in a dose-dependent manner on HL-60 cells both 24 and 48 h after MB treatment. MB-induced apoptosis was through the caspase-mediated pathway, by activation of caspase-3. Furthermore, a lactate dehydrogenase (LDH) release test suggested that an MB-cholesterol interaction led to the rearrangement of the lipid bilayer and to subsequent cell membrane impairment. Taken together, these findings demonstrate that MB may exhibit cytotoxic activity against HL-60 cells by inducing apoptosis via caspase-dependent pathways and also membrane permeabilisation.     

量子点-卟啉纳米复合体系在肿瘤细胞成像中的应用

本文合成了高荧光量子产率、单分散性好的水溶性CdTe量子点(quantum dots,QDs),并与α,β,γ,δ-四(1-甲基吡啶嗡-4-基)卟吩对甲苯磺酸盐(TMPyP)组装成QDs-TMPyP纳米复合物,研究了该复合物检测DNA的机理以及肿瘤细胞成像。结果显示,QDs-TMPyP纳米复合物通过光致电子转移机制检测DNA,当CdTe QDs和CdTe QDs-TMPyP浓度低于1.0μmol/L时,HeLa肿瘤细胞存活率达92%以上,表现出低的细胞毒性。0.2μmol/L CdTe QDs-TMPyP作用于肿瘤细胞时,细胞生长状态良好,对细胞内能谱分析发现细胞内含有Cd和Te原子。CdTe QDs-TMPyP复合物比CdTe QDs更易被HeLa细胞摄取,利用量子点荧光成功实现了细胞核内成像,为宫颈癌细胞药物输送和细胞成像的深入研究打下基础。     

γ-聚谷氨酸在细胞冻存中的作用

无DMSO、无血清细胞冻存液在临床级细胞产品的冷冻保存中具有重要的应用价值。本文以K562细胞为模型,设置含10%(v/v)DMSO及胎牛血清的冻存液为阳性对照,含10%(v/v)甘油的RPMI 1640培养基冻存液为阴性对照组,含10%(v/v)甘油及0.01%(w/v)γ-PGA的RPMI 1640培养基冻存液为实验组,考察了在无DMSO、无血清细胞冻存体系中γ-聚谷氨酸对细胞的冷冻保护作用。将K562细胞以1×10^6cells/mL的密度分别悬浮在上述冻存液中,置于液氮冻存10周,检测复苏后K562的细胞复苏率、细胞形态以及复苏后细胞的扩增情况,以评判γ-聚谷氨酸在无DMSO无血清冻存液中对K562细胞的冷冻保护作用。结果显示,实验组的细胞复苏率为(83.00±3.00)%,明显高于阴性对照组的(70.33±5.51)%(p<0.05)和阳性对照组的(71.00±2.65)%(p<0.05);且实验组冻存后的细胞形态完整,冻存前后细胞的平均直径及圆度基本一致,细胞复苏后培养24h后的细胞活性为(88.83±14.29)%,明显高于阴性对照组的(67.51±5.20)%(p<0.05),与阳性对照组的(78.75±3.31)%没有显著性差异,同时复苏后细胞扩增的延滞期明显缩短。可见,在无DMSO、无血清的甘油冻存体系中添加γ-PGA可显著提高细胞的冻存效果,具有良好的实际应用价值。     

基于表面等离子体子共振成像技术研究苏拉明和顺铂对肝癌细胞生长的抑制作用简

基于表面等离子体子共振成像(SPRi)技术提出了一种实时、非标记的新型抗癌药物药效评估方法. 以聚二甲基硅氧烷(PDMS)为材料,制作了包含微柱结构的微流控芯片作为流通反应池,配合自行设计组装的SPRi生物传感器完成肿瘤细胞的特异性捕获及检测,研究了苏拉明和顺铂对肝癌细胞HepG2的生长抑制作用. 同时引入辅助验证实验,即采用常规八肽胆囊收缩素(简称CCK-8)法测定上述药物对肝癌细胞增殖的抑制作用. SPRi检测结果表明,苏拉明和顺铂能抑制肿瘤细胞HepG2增殖并呈现剂量、时间依赖关系.     

基于表面等离子体子共振成像技术研究苏拉明和顺铂对肝癌细胞生长的抑制作用

基于表面等离子体子共振成像(SPRi)技术提出了一种实时、 非标记的新型抗癌药物药效评估方法. 以聚二甲基硅氧烷(PDMS)为材料, 制作了包含微柱结构的微流控芯片作为流通反应池, 配合自行设计组装的SPRi生物传感器完成肿瘤细胞的特异性捕获及检测, 研究了苏拉明和顺铂对肝癌细胞HepG2的生长抑制作用. 同时引入辅助验证实验, 即采用常规八肽胆囊收缩素(简称CCK-8)法测定上述药物对肝癌细胞增殖的抑制作用. SPRi检测结果表明, 苏拉明和顺铂能抑制肿瘤细胞HepG2增殖并呈现剂量、 时间依赖关系.     

硒化壳聚糖抑制人早幼粒白血病细胞增殖的研究

为探讨硒化壳聚糖对体外培养人早幼粒白血病细胞增殖的抑制作用,用SRB法和集落形成法检测了药物对细胞增殖的抑制作用,流式法检测了细胞周期阻断作用。结果表明,25、50、100mg／L硒化壳聚糖作用HL60细胞48h对细胞有增殖抑制作用（P〈0．01）;50、100mg／L硒化壳聚糖作用细胞48h后,G0／G1期细胞数较对照组增加了14．9％-22．0％（P〈0．05）,S期细胞减少了14．3％～20．1％（P〈0．05）。可见硒化壳聚糖对人早幼粒白血病细胞增殖具有抑制作用。     

A pumpless cell culture chip with the constant medium perfusion-rate maintained by balanced droplet dispensing

This paper presents a pumpless cell culture chip, where a constant-rate medium perfusion is achieved by balanced droplet dispensing. Previous pumpless cell culture chips, where the gravity-driven flow is induced by gradually decreasing the hydraulic-head difference, Δh, between source and drain reservoirs, result in a decreasing perfusion-rate. However, the present pumpless cell culture chip, where autonomous droplet dispensers are integrated on the source reservoirs, results in a constant perfusion-rate using a constant Δh maintained by balanced droplet dispensing between the source-inlet and the drain-outlet. In the experimental study, constant perfusion-rates of 0.1, 0.2, and 0.3 μl min(-1) are obtained by Δh of 38, 76, and 114 mm, respectively. At the constant perfusion-rate (Q=0.2 μl min(-1)), H358 lung cancer cells show the maximum growth-rate of 57.8 ± 21.1% d(-1), which is 1.9 times higher than the 30.2 ± 10.3% d(-1) of the static culture. At a perfusion-rate varying between 0.1-0.3 μl min(-1) (average=0.2 μl min(-1)), however, the H358 cells show a growth-rate of 46.9 ± 8.3% d(-1), which is lower than that of the constant Q of 0.2 μl min(-1). The constant-rate perfusion culture (Q=0.1, 0.2, and 0.3 μl min(-1)) also results in an average cell viability of 89.2%, which is higher than 75.9% of the static culture. This pumpless cell culture chip offers a favorable environment to cells with a high growth-rate and viability, thus having potential for use in cell-based bio-assays.     

Inhibitory Effects and Mechanism of the Natural Compound Diaporthein B Extracted from Marine-Derived Fungi on Colon Cancer Cells

This study aimed to investigate the inhibitory effects and mechanism of diaporthein B (DTB), a natural compound extracted from the fungus Penicillium sclerotiorum GZU-XW03-2, on human colon cancer cells. The inhibitory effect of DTB at different concentrations on the proliferation of colon cancer cells HCT116 and LOVO was detected at 24 and 48 h. The effect of cell migration and clone formation ability were detected by cell scratch and plate cloning experiments. Morphological changes were observed by Hoechst 33342 and Annexin-V/PI staining, and flow cytometry was used to detect the proportion of apoptotic cells. DTB significantly inhibited colon cancer cell proliferation, migration, and apoptosis in a dose-dependent manner without significant effects on normal colonic epithelial cells NCM460. The IC50 inhibition effect can be achieved after treatment with 3 μmol/L DTB for 24 h. Compared with the blank group, the migration and clonal-forming ability of colon cancer cells in the DTB group was significantly decreased (p < 0.01), while the apoptotic cells were significantly increased (p < 0.01) in a concentration-dependent manner. DTB can inhibit the proliferation and migration of human colon cancer cells HCT116 and LOVO and promote the apoptosis of human colon cancer cells.